Lipid-Based Nanoformulations for Drug Delivery: An Ongoing Perspective
Pharmaceutics · 26.10.2024 · 16 (11) · 1376
DOI: 10.3390/pharmaceutics16111376 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 26.10.2024. Verfasst von Mubashar Rehman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 45320, Pakistan. Die Arbeit wurde bisher 110-mal zitiert (Crossref) und nennt 245 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Fundação para a Ciência e a Tecnologia (FCT), Portugal.
Abstract (Originalsprache)
Oils and lipids help make water-insoluble drugs soluble by dispersing them in an aqueous medium with the help of a surfactant and enabling their absorption across the gut barrier. The emergence of microemulsions (thermodynamically stable), nanoemulsions (kinetically stable), and self-emulsifying drug delivery systems added unique characteristics that make them suitable for prolonged storage and controlled release. In the 1990s, solid-phase lipids were introduced to reduce drug leakage from nanoparticles and prolong drug release. Manipulating the structure of emulsions and solid lipid nanoparticles has enabled multifunctional nanoparticles and the loading of therapeutic macromolecules such as proteins, nucleic acid, vaccines, etc. Phospholipids and surfactants with a well-defined polar head and carbon chain have been used to prepare bilayer vesicles known as liposomes and niosomes, respectively. The increasing knowledge of targeting ligands and external factors to gain control over pharmacokinetics and the ever-increasing number of synthetic lipids are expected to make lipid nanoparticles and vesicular systems a preferred choice for the encapsulation and targeted delivery of therapeutic agents. This review discusses different lipids and oil-based nanoparticulate systems for the delivery of water-insoluble drugs. The salient features of each system are highlighted, and special emphasis is given to studies that compare them.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 45320, Pakistan.
- College of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan.
- Wellman Center of Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
- Department of Pharmacy, University of South Asia, Lahore 54000, Pakistan.
- Department of Pharmacy, Faculty of Health and Medical Sciences, The University of Copenhagen, 1172 København, Denmark.
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia.
ORCID-Profile: Mubashar Rehman, Muhammad Farhan Sohail, Sofia O D Duarte, Pedro Brandão, Teresa Esteves, Pedro Fonte
Förderung
- Fundação para a Ciência e Tecnologia
- Fundação para a Ciência e a Tecnologia (FCT), Portugal
Zitieren
APA
Rehman, M., Tahir, N., Sohail, M. F., Qadri, M. U., Duarte, S. O. D., Brandão, P., Esteves, T., Javed, I., & Fonte, P. (2024). Lipid-Based Nanoformulations for Drug Delivery: An Ongoing Perspective. Pharmaceutics, 16(11), 1376. https://doi.org/10.3390/pharmaceutics16111376
Vancouver
Rehman M, Tahir N, Sohail MF, Qadri MU, Duarte SOD, Brandão P, et al. Lipid-Based Nanoformulations for Drug Delivery: An Ongoing Perspective. Pharmaceutics. 2024;16(11):1376. doi:10.3390/pharmaceutics16111376
BibTeX
@article{Rehman2024,
author = {Rehman, Mubashar and Tahir, Nayab and Sohail, Muhammad Farhan and Qadri, Muhammad Usman and Duarte, Sofia O D and Brandão, Pedro and Esteves, Teresa and Javed, Ibrahim and Fonte, Pedro},
title = {Lipid-Based Nanoformulations for Drug Delivery: An Ongoing Perspective},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {11},
pages = {1376},
doi = {10.3390/pharmaceutics16111376}
}
EUVIMED